United States Patent and Trademark Office OG Notices: 18 June 2002
Date Type of Proceeding
Issued Case (1) or App'n No. Party/Parties
5-9 OPP 111,332 King Bio
Pharmaceuticals,
Inc. v. King
Pharmaceuticals,
Inc.
5-9 EX 75/931,500 Wyndham IP Corp.
Opposer's/ Applicant's/
Petitioner's Respondent's
TTAB Mark and Mark and
Issue Decision Goods/Services Goods/Services
2(d); Opposition "KING
affirmative Sustained PHARMACEUTICALS,"
defense "KING BIO "KING"
asserting PHARMACEU- (and design),
opposer's TICALS" and
mark is [non- "KING
primarily prescription PHARMACEUTICALS"
merely a homeopathic (and design)
surname and remedies] [all three marks
not distinc- for pharmaceuti-
tive as a cals for human and
trademark for veterinary use,
opposer's namely, morphine,
goods codeine, and
related inject-
ables; cough
syrup,
antihistamines,
decongestants,
dermatological
preparations, and
vitamins]
Section 6 Refusal "WYNDHAM WIRED"
disclaimer Affirmed [hotel services,
requirement namely, offering
(of the high-technology
word WIRED) room furnishings
upgrades to
business
travelers]
Mark and Citable as
Goods Cited by Precedent
Examining Atty. of TTAB
No
No
(1)EX=EX PARTE APPEAL; OPP=OPPOSITION; CANC=CANCELLATION; CU=CONCURRENT
USE; (SJ)=SUMMARY JUDGMENT; (R)=REQ. FOR RECONSIDERATION; (MD)=MOTION
TO DISMISS; (MR)=MOTION TO REOPEN